Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

bioAffinity Technologies (BIAF) Depreciation & Amortization (IS) (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Depreciation & Amortization (IS) for 4 consecutive years, with $123659.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (IS) fell 19.51% to $123659.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $504836.0 through Dec 2025, down 16.64% year-over-year, with the annual reading at $504836.0 for FY2025, 16.64% down from the prior year.
  • Depreciation & Amortization (IS) for Q4 2025 was $123659.0 at bioAffinity Technologies, up from $113360.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (IS) was $154588.0 in Q1 2025, with the low at $773.0 in Q3 2022.
  • Average Depreciation & Amortization (IS) over 4 years is $97726.3, with a median of $118509.5 recorded in 2025.
  • The sharpest move saw Depreciation & Amortization (IS) skyrocketed 7347.48% in 2023, then dropped 25.08% in 2025.
  • Over 4 years, Depreciation & Amortization (IS) stood at $7330.0 in 2022, then skyrocketed by 1929.84% to $148787.0 in 2023, then grew by 3.26% to $153632.0 in 2024, then fell by 19.51% to $123659.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (IS) over the past three periods came in at $123659.0, $113360.0, and $113229.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.